EC Number | Activating Compound | Comment | Organism | Structure |
---|---|---|---|---|
1.13.99.1 | additional information | increased secretion in a dose-dependent manner after high-glucose treatment | Rattus norvegicus |
EC Number | Cloned (Comment) | Organism |
---|---|---|
1.13.99.1 | transfection into NRK-52E cells | Rattus norvegicus |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
1.13.99.1 | Rattus norvegicus | - |
control group and diabetes group | - |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
1.13.99.1 | renal cortex | - |
Rattus norvegicus | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.13.99.1 | myo-inositol + O2 | - |
Rattus norvegicus | D-glucuronic acid + H2O | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
1.13.99.1 | MIOX | - |
Rattus norvegicus |
1.13.99.1 | Myo-inositol oxygenase | - |
Rattus norvegicus |
EC Number | Organism | Comment | Expression |
---|---|---|---|
1.13.99.1 | Rattus norvegicus | diabetic, nephropathy | up |
EC Number | General Information | Comment | Organism |
---|---|---|---|
1.13.99.1 | malfunction | increased expression in diabetic kidneys may contribute to tubulointerstitial injury and development of diabetic nephropathy | Rattus norvegicus |